Ratings by H.C. Wainwright (Michael King)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/23/2022 | Scholar Rock | SRRK | New Coverage | Buy (N/A) |
12.99 (42.49) |
227.1% | Details | |
| 3/11/2022 | Lantern Pharma Inc. | LTRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2022 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2021 | Lantern Pharma Inc. | LTRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2021 | Compass Therapeutics | CMPX | New Coverage | Buy (N/A) |
3.25 (0.75) |
-76.92% | Details | |
| 10/11/2021 | Cogent | COGT | New Coverage | Buy (N/A) |
7.60 (32.01) |
321.18% | Details | |
| 10/7/2021 | Lantern Pharma Inc. | LTRN | New Coverage | Buy (N/A) |
9.49 (0.64) |
-93.26% | Details | |
| 8/25/2021 | Salarius Pharmaceuticals | SLRX | New Coverage | Buy (N/A) |
0.94 (0.84) |
-10.64% | Details | |
| 6/29/2021 | Regeneron Pharma | REGN | New Coverage | Buy (N/A) |
542.70 (816.10) |
50.38% | Details | |
| 6/15/2021 | Exelixis | EXEL | New Coverage | Buy (N/A) |
22.76 (65.35) |
187.13% | Details | |
| 5/25/2021 | Werewolf Therapeutics Inc. | HOWL | New Coverage | Buy (N/A) |
12.18 (1.04) |
-91.46% | Details |
